| Mon, 01 Mar 2021 16:32:45: | J&J’s next COVID-19 vaccine challenge? Hurdling the ‘66%’ perception to win over a vaccine-hesitant public
|
| Mon, 01 Mar 2021 16:18:38: | W.R. Grace lays out $570M for Albemarle unit to bolster pharma portfolio, API manufacturing
|
| Mon, 01 Mar 2021 16:04:16: | AstraZeneca licenses Junshi's PD-1 in China in a bizarre commercialization deal
|
| Mon, 01 Mar 2021 15:00:18: | 'Hub-and-spoke' biotech BridgeBio scores first FDA approval with Alexion castoff
|
| Mon, 01 Mar 2021 14:21:28: | Perrigo's generics split is back on the docket, thanks to $1.55B Altaris offer
|
| Fri, 26 Feb 2021 20:32:45: | Johnson & Johnson's COVID-19 vaccine scores FDA authorization, adding key third shot to U.S. supply
|
| Fri, 26 Feb 2021 19:16:38: | Otsuka 'Big Kidney' campaign targets HCPs in bid to shift diagnostic standards
|
| Fri, 26 Feb 2021 16:00:43: | Vials maker Stevanto plans IPO as coronavirus vaccine companies clamor for packaging: Reuters
|
| Fri, 26 Feb 2021 15:06:25: | FDA waves through a 3rd Sarepta DMD drug, once again based on questionable biomarker data
|
| Fri, 26 Feb 2021 14:03:01: | Lilly scores $210M supply deal for newly authorized coronavirus antibody cocktail
|
| Fri, 26 Feb 2021 13:45:21: | Novo Nordisk re-engages comedian Billy Gardell for branded Ozempic campaign
|
| Fri, 26 Feb 2021 13:28:41: | Rocket Pharma spurs more buildings and landmarks to light up for Rare Disease Day
|
| Fri, 26 Feb 2021 10:06:32: | Fierce Pharma Asia—Daiichi Sankyo's new R&D head; Clover's $230M raise; Insilico's AI breakthrough
|
| Thu, 25 Feb 2021 15:26:27: | 3-shot combo? Pfizer, BioNTech roll COVID-19 booster trial as real-world data back first vaccine
|
| Thu, 25 Feb 2021 14:43:14: | Ready to square off with Pfizer in next-gen pneumococcal vaccines, a Merck exec says competition's a good thing
|
| Thu, 25 Feb 2021 14:10:21: | Novo Nordisk plots $82M tablet capacity upgrade for diabetes blockbuster-to-be Rybelsus
|
| Wed, 24 Feb 2021 23:13:02: | Epizyme shouldn't blame COVID-19 alone for sluggish launch of its cancer med Tazverik: analysts
|
| Wed, 24 Feb 2021 20:10:24: | 'Mission Possible': Pfizer and BioNTech star in their own vaccine discovery movie
|
| Wed, 24 Feb 2021 19:46:40: | Moderna sends COVID-19 booster shot for NIH testing as it hikes production targets past 2B doses
|
| Wed, 24 Feb 2021 19:40:56: | With $900M IPO, SK Bioscience has big plans for manufacturing expansion—even beyond COVID-19 vaccines
|
| Wed, 24 Feb 2021 15:57:25: | Merck rolls first Gardasil TV commercial that pushes HPV vaccines for adults
|
| Wed, 24 Feb 2021 14:55:20: | AstraZeneca to tap global COVID-19 vaccine supply chain to fulfill Q2 deliveries to Europe
|
| Wed, 24 Feb 2021 14:16:13: | Fledgling CDMO Lakes BioScience blueprints $490M antibody factory at ex-GlaxoSmithKline site
|
| Wed, 24 Feb 2021 13:29:43: | Novartis' first Kesimpta ad push offers break from relapsing MS 'drama'
|
| Tue, 23 Feb 2021 22:01:26: | Catalent continues cell and gene therapy push with deal for Belgian CDMO
|
